A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet
Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This is a multisite study to evaluate the efficacy, safety and plasma concentration of
Nalfurafine Hydrochloride orally disintegrating tablet in the treatment of refractory
pruritus in maintenance hemodialysis patients, and to bridge the efficacy data from Japan